The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Achilles Therapeutics
Patents, Royalties, Other Intellectual Property - Methods for lung cancer detection – patent number PCT/US2017/28013 (joint inventor). This patent encompasses the methods using ctDNA for detecting single nucleotide variants in lung cancer, especially stage 3a lung adenocarcinoma and lung squamous cell ca (Inst)
Association of the imbalance between early and late differentiated intra-tumor CD4 T cells with mutational burden in non-small cell lung cancer.
 
Ehsan Ghorani
No Relationships to Disclose
 
James L. Reading
No Relationships to Disclose
 
Jake Y. Henry
No Relationships to Disclose
 
Marc Robert De Massy
No Relationships to Disclose
 
Rachel Rosenthal
Stock and Other Ownership Interests - Achilles Therapeutics
Consulting or Advisory Role - Achilles Therapeutics
Patents, Royalties, Other Intellectual Property - Patent WO2017042394 A1 :Methods for identifying a subject with cancer who is suitable for treatment with an immune checkpoint intervention
 
Andrew J.S. Furness
No Relationships to Disclose
 
Assma Ben Aissa
No Relationships to Disclose
 
Mariam Jamal-Hanjani
No Relationships to Disclose
 
Nicolai Birkbak
No Relationships to Disclose
 
Gareth Wilson
No Relationships to Disclose
 
Roberto Salgado
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - Merck; Puma Biotechnology
Travel, Accommodations, Expenses - Merck; Roche
 
Tom Lund
No Relationships to Disclose
 
Crispin T. Hiley
No Relationships to Disclose
 
Sherene Loi
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
 
Allan Hackshaw
No Relationships to Disclose
 
Nicholas McGranahan
Stock and Other Ownership Interests - Achilles Therapeutics
Consulting or Advisory Role - Achilles Therapeutics
Patents, Royalties, Other Intellectual Property - Patent WO2016174085 A1: Method for treating cancer based on identification of clonal neo-antigens (Inst)
 
Benjamin M. Chain
No Relationships to Disclose
 
Karl S. Peggs
Stock and Other Ownership Interests - Achilles Therapeutics
Consulting or Advisory Role - Achilles Therapeutics
Patents, Royalties, Other Intellectual Property - Patent WO2016174085 A1: Method for treating cancer based on identification of clonal neo-antigens (Inst)
 
Charles Swanton
Stock and Other Ownership Interests - Achilles Therapeutics; Apogen Biotechnologies; Epic Sciences; GRAIL
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Illumina; Lilly; Novartis; Ono Pharmaceutical; Pfizer; Roche; SERVIER
Consulting or Advisory Role - Genentech/Roche; Sarah Cannon Research Institute
Research Funding - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Founder of Achilles Therapeutics: a biotechnology company funded by Syncona/Wellcome Trust to target clonal Neoantigens through vaccine and cell therapy approaches; Patent WO2016174085 A1: Method for treating cancer based on identification of clonal neo-antigens; Patent WO2017042394 A1 :Methods for identifying a subject with cancer who is suitable for treatment with an immune checkpoint intervention
 
Sergio A. Quezada
Stock and Other Ownership Interests - Achilles Therapeutics
Consulting or Advisory Role - Achilles Therapeutics
Patents, Royalties, Other Intellectual Property - Patent WO2016174085 A1: Method for treating cancer based on identification of clonal neo-antigens (Inst)